XOMA Competitors and Similar CompaniesClear all
XOMA's competitors and similar companies include Humanigen, Pfizer and Moderna.
 XOMA XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics. |  Humanigen Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. | |
Founding Date | Founding Date 1981 | Founding Date 2000 | Founding Date 1849 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Emeryville, US HQ | Locations Burlingame, US HQ Dublin, IE London, GB Kansas City, US | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | |
Employees | Employees 109% decrease | Employees 233% decrease | Employees 81,0008% decrease | Employees 5,8004% increase |
Valuation ($) | Valuation ($) 353.7 m | Valuation ($) 4.3 m | Valuation ($) 163.9 b | Valuation ($) 21.2 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $52.1m (FY, 2025) | Revenue (est.) $2.5m (FY, 2022) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $1.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $16.1b (FY, 2025) | Cost of goods $868m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $46.5b (FY, 2025) | Gross profit $1.1b (FY, 2025) |
Net income | Net income $31.7m (FY, 2025) | Net income ($70.7m) (FY, 2022) | Net income $7.8b (FY, 2025) | Net income ($2.8b) (FY, 2025) |
Operating ⚠ | ||||
Patent Applications | Patent Applications N/A | Patent Applications 17 (FY, 2017) | Patent Applications N/A | Patent Applications 430 (FY, 2021) |
Patents (Foreign) | Patents (Foreign) N/A | Patents (Foreign) 42 (FY, 2017) | Patents (Foreign) N/A | Patents (Foreign) 110 (FY, 2021) |
Patents (US) | Patents (US) N/A | Patents (US) 18 (FY, 2017) | Patents (US) N/A | Patents (US) 170 (FY, 2021) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 131.7m | Total funding raised N/A | Total funding raised $ 1.8b |
For sources of this data, please see the company profile
View Company Profiles
Humanigen
HQ
Burlingame, US
Employees
2↓ 33% decrease
Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyModerna
HQ
Cambridge, US
Employees
5,800↑ 4% increase
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View company